Nuo Therapeutics (AURX) EBIT Margin (2010 - 2026)
Nuo Therapeutics' EBIT Margin came in at -9.42% for Q2 2026, up 83.70 percentage points from -93.12% a year earlier.
Powered by 
Analysis
Nuo Therapeutics (AURX) EBIT Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Nuo Therapeutics reported EBIT Margin of -42.15%, up 91.35 percentage points year-over-year; for FY2025, it was -75.95%, up 104.09 percentage points from FY2024.
- EBIT Margin has increased in each of the last three years, with a three-year change of +2882.26 percentage points (FY2022 to FY2025).
- Going back by year, EBIT Margin was -180.04% in FY2024 (+340.61 pp), -520.65% in FY2023 (+2437.56 pp) and -2958.21% in FY2022.
- The Q2 2026 figure represents the highest quarterly EBIT Margin since Q4 2019.
- Across the past five years, year-over-year gain in EBIT Margin ran from 55.46 percentage points in Q2 2025 to 2043.99 percentage points in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 257.99 Bn | 237.02 Bn | 4.88 Bn | 17.40% |
| 2 | Abbott Laboratories | 175.01 Bn | 145.44 Bn | 7.27 Bn | 13.44% |
| 3 | Danaher | 164.93 Bn | 148.74 Bn | 3.61 Bn | 17.99% |
| 4 | Intuitive Surgical | 151.84 Bn | 131.26 Bn | 1.96 Bn | 33.60% |
| 5 | Medtronic | 119.05 Bn | 84.30 Bn | 6.34 Bn | 18.08% |
| 6 | Stryker | 113.89 Bn | 100.00 Bn | 4.50 Bn | 25.18% |
| 7 | Boston Scientific | 65.37 Bn | 60.13 Bn | 3.85 Bn | 21.65% |
| 8 | Becton Dickinson | 53.36 Bn | 50.51 Bn | 2.32 Bn | 13.31% |
| 9 | Edwards Lifesciences | 50.83 Bn | 34.83 Bn | 1.35 Bn | 29.48% |
| 10 | Nuo Therapeutics | 62.45 Mn | 60.62 Mn | 1.17 Mn | -9.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.42% |
| Dec 31, 2025 | -52.82% |
| Sep 30, 2025 | -52.33% |
| Jun 30, 2025 | -93.12% |
| Mar 31, 2025 | -153.83% |
| Dec 31, 2024 | -159.35% |
| Sep 30, 2024 | -155.65% |
| Jun 30, 2024 | -148.58% |
| Mar 31, 2024 | -302.35% |
| Dec 31, 2023 | -330.99% |
| Sep 30, 2023 | -339.97% |
| Jun 30, 2023 | -737.44% |
| Mar 31, 2023 | -1,399.66% |
| Dec 31, 2022 | -1,301.60% |
| Sep 30, 2022 | -2,383.96% |
| Dec 31, 2019 | 1,505.55% |
| Sep 30, 2019 | -66.85% |
| Jun 30, 2019 | -888.59% |
| Mar 31, 2019 | -1,559.64% |
| Dec 31, 2018 | 19.39% |
API Access
Nuo Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=AURX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "AURX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=AURX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();